These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11895104)

  • 21. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.
    Shiraki M; Shiraki Y; Aoki C; Miura M
    J Bone Miner Res; 2000 Mar; 15(3):515-21. PubMed ID: 10750566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia.
    Purwosunu Y; Muharram ; Rachman IA; Reksoprodjo S; Sekizawa A
    J Obstet Gynaecol Res; 2006 Apr; 32(2):230-4. PubMed ID: 16594930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menatetrenone ameliorates reduction in bone mineral density and bone strength in sciatic neurectomized rats.
    Iwasaki-Ishizuka Y; Yamato H; Murayama H; Abe M; Takahashi K; Kurokawa K; Fukagawa M; Ezawa I
    J Nutr Sci Vitaminol (Tokyo); 2003 Aug; 49(4):256-61. PubMed ID: 14598912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin K₂ prevents hyperglycemia and cancellous osteopenia in rats with streptozotocin-induced type 1 diabetes.
    Iwamoto J; Seki A; Sato Y; Matsumoto H; Takeda T; Yeh JK
    Calcif Tissue Int; 2011 Feb; 88(2):162-8. PubMed ID: 21136047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K2, a gamma-carboxylating factor of gla-proteins, normalizes the bone crystal nucleation impaired by Mg-insufficiency.
    Amizuka N; Li M; Kobayashi M; Hara K; Akahane S; Takeuchi K; Freitas PH; Ozawa H; Maeda T; Akiyama Y
    Histol Histopathol; 2008 Nov; 23(11):1353-66. PubMed ID: 18785118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of vitamin K2 on cortical and cancellous bone mass, cortical osteocyte and lacunar system, and porosity in sciatic neurectomized rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Yeh JK
    Calcif Tissue Int; 2010 Sep; 87(3):254-62. PubMed ID: 20556371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of vitamin K2 administration in the patients with severely motor and intellectual disabilities: assessment of bone metabolic marker and bone mineral density].
    Tanaka Y; Shibata R
    No To Hattatsu; 2000 Nov; 32(6):491-6. PubMed ID: 11144162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa.
    Iketani T; Kiriike N; Murray ; Stein B; Nagao K; Nagata T; Minamikawa N; Shidao A; Fukuhara H
    Psychiatry Res; 2003 Mar; 117(3):259-69. PubMed ID: 12686368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of menatetrenone on bone loss induced by ovariectomy in rats.
    Akiyama Y; Hara K; Ohkawa I; Tajima T
    Jpn J Pharmacol; 1993 Jun; 62(2):145-53. PubMed ID: 8371513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.
    Kobayashi M; Hara K; Akiyama Y
    Bone; 2004 Nov; 35(5):1136-43. PubMed ID: 15542039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menatetrenone rescues bone loss by improving osteoblast dysfunction in rats immobilized by sciatic neurectomy.
    Iwasaki-Ishizuka Y; Yamato H; Murayama H; Ezawa I; Kurokawa K; Fukagawa M
    Life Sci; 2005 Feb; 76(15):1721-34. PubMed ID: 15698851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Nutr Rev; 2006 Dec; 64(12):509-17. PubMed ID: 17274493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin K(2) improves renal function and increases femoral bone strength in rats with renal insufficiency.
    Iwamoto J; Seki A; Sato Y; Matsumoto H
    Calcif Tissue Int; 2012 Jan; 90(1):50-9. PubMed ID: 22080166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preventive and interventional effects of raloxifene analog (LY117018 HCL) on osteopenia in ovariectomized rats.
    Li X; Takahashi M; Kushida K; Inoue T
    J Bone Miner Res; 1998 Jun; 13(6):1005-10. PubMed ID: 9626632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low dose phenytoin is an osteogenic agent in the rat.
    Ohta T; Wergedal JE; Gruber HE; Baylink DJ; Lau KH
    Calcif Tissue Int; 1995 Jan; 56(1):42-8. PubMed ID: 7796345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of trabecular structure and bone volume by vitamin K(2) in mature rats with long-term tail suspension.
    Iwasaki Y; Yamato H; Murayama H; Sato M; Takahashi T; Ezawa I; Kurokawa K; Fukagawa M
    J Bone Miner Metab; 2002; 20(4):216-22. PubMed ID: 12115067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics of menatetrenone and effects on bone metabolism in continuous ambulatory peritoneal dialysis patients.
    Sugimoto T; Yamakado M; Matsushita K; Iwamoto T; Tagawa H
    J Int Med Res; 2002; 30(6):566-75. PubMed ID: 12526283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A calcium-deficient diet caused decreased bone mineral density and secondary elevation of estrogen in aged male rats-effect of menatetrenone and elcatonin.
    Kato S; Mano T; Kobayashi T; Yamazaki N; Himeno Y; Yamamoto K; Itoh M; Harada N; Nagasaka A
    Metabolism; 2002 Oct; 51(10):1230-4. PubMed ID: 12370839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women.
    Ozuru R; Sugimoto T; Yamaguchi T; Chihara K
    Endocr J; 2002 Jun; 49(3):363-70. PubMed ID: 12201222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.